Patents by Inventor Stephen William Rafferty

Stephen William Rafferty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor
    Publication number: 20090093464
    Abstract: The present invention relates to naphthalene derivatives of formula (I) that are modulators of the glucocorticoid receptor, and to processes for the preparation and use of the same.
    Type: Application
    Filed: February 21, 2006
    Publication date: April 9, 2009
    Applicant: SMITHKLINE BEECHMA CORPORATION
    Inventors: Stephen William Rafferty, Philip Stewart Turnbull, Eugene Lee Stewart, Richard Dana Caldwell
  • Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
    Patent number: 7449468
    Abstract: The present invention provides a compound of formula (I): wherein R1-R5, R25, R26, Y, y, and X2are as defined herein. The compounds activate human peroxisome proliferater activated receptors (hPPARs) and are useful for the treatment of associated disorders such as dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: November 11, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Pierette Banker, Rodolfo Cadilla, Millard Hurst Lambert, III, Stephen William Rafferty, Daniel David Sternbach, Marcos Luis Sznaidman
  • Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
    Patent number: 7229998
    Abstract: The present invention provides a compound of formula (I): wherein R1–R5, R25, R26, Y and X2 are as defined herein. The compounds activate human peroxisome proliferator activated receptors (hPPARs) and are useful for the treatment of associated disorders such as cardiovascular disease and hypercholesteremia.
    Type: Grant
    Filed: October 17, 2006
    Date of Patent: June 12, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Rodolfo Cadilla, Millard Hurst Lambert, III, Stephen William Rafferty, Daniel David Sternbach
  • Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
    Publication number: 20040072838
    Abstract: The present invention provides a compound of formula (1) wherein R1-R5, R25, R26, Y and X2 are defined as in claim 1. The compounds activate human peroxisome proliferator activated receptors (hPPARs) and arc useful for the treatment of associated disorders such as cardiovascular disease and hypercholesteremia.
    Type: Application
    Filed: October 31, 2003
    Publication date: April 15, 2004
    Inventors: Pierette Banker, Rodolfo Cadilla, Millard Hurst Lambert lll, Stephen William Rafferty, Daniel David Sternbach, Marcos Luis Sznaidman